科研之友
微信
新浪微博
Facebook
分享链接
摘要
New therapeutics, such as ivacaftor, and the combination drug lumacaftor/ ivacaftor that target the underlying genetic cause of cystic fibrosis are being hailed as game-changers in this era of personalized medicine. Although these drugs improve lung function, their effects on female fertility have not been studied. In this case report we describe one woman's experience with ivacaftor and her unanticipated pregnancy. Implications related to comprehensive sexual and reproductive health care for women with cystic fibrosis are presented.
- 出版日期2017-2
